Risk communication in consultations about hormone therapy in the menopause:: concordance in risk assessment and framing due to the context

被引:8
|
作者
Hoffmann, M.
Hammar, M.
Kjellgren, K. I.
Lindh-Astrand, L.
Ahlner, J.
机构
[1] Linkoping Univ, Div Clin Pharmacol, Dept Med & Care, Fac Hlth Sci, Linkoping, Sweden
[2] Linkoping Univ, Dept Obstet & Gynecol, Dept Mol & Clin Med, Fac Hlth Sci, Linkoping, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Inst Nursing, Fac Hlth & Caring Sci, Gothenburg, Sweden
[4] Nalt Board Forens Med, Dept Forens Chem, Linkoping, Sweden
关键词
risk; risk assessment; communication; physician-patient relations; professional-patient relations;
D O I
10.1080/13697130600870220
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background It is important for the physician and the patient to have a mutual understanding of the possible consequences of different treatment alternatives in order to achieve a partnership in decision-making. Objective The aim of this study was to explore to which degree first-time consultations for discussion of climacteric discomfort achieved shared understanding of the risks and benefits associated with hormone therapy in the menopausal transition. Methods Analysis of structure and content of transcribed consultations (n=20), and follow-up interviews of the women (n=19 pairs of consultations and interviews), from first-time visits for discussion of climacteric discomfort and/or HT with five physicians at three different outpatient clinics of gynecology in Sweden. Results Four distinctively different interpretations of risk, depending on whether or not benefits were discussed in the same context, emerged from the analysis. On average, five advantages (range 0-11) and two (0-3) disadvantages were mentioned during the consultations. In the interviews, the women expressed on average four advantages (0-7) and one disadvantage (0-3). There were major variations between advantages and disadvantages expressed in the consultation and the following interview. Conclusion Even though the consultations scored high in patient involvement, the information in most consultations was not structured in a way that made it possible to achieve a shared or an informed decision-taking.
引用
收藏
页码:347 / 354
页数:8
相关论文
共 50 条
  • [21] Hormone substitution therapy for menopause reduces the risk of colorectal cancer
    Blanc, JF
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2004, 28 (11): : 1193 - 1194
  • [22] Framing effects in risk communication messages - Hazard identification vs. risk assessment
    Freudenstein, F.
    Croft, R. J.
    Wiedemann, P. M.
    Verrender, A.
    Boehmert, C.
    Loughran, S. P.
    ENVIRONMENTAL RESEARCH, 2020, 190
  • [23] Social context for communication about radiation risk.
    Flynn, JH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U66 - U66
  • [24] The Influence of Time From Menopause and Mammography on Hormone Therapy-Related Breast Cancer Risk Assessment
    Chlebowski, Rowan T.
    Anderson, Garnet L.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (04) : 284 - 285
  • [25] Hormone replacement therapy in menopause as a risk factor for developing breast cancer
    Souto, Natasha Firmino
    Moreira, Camila Brasil
    Soares Barros, Paulo Augusto
    Carvalho Fernandes, Ana Fatima
    Lavinas Santos, Miria Conceicao
    REVISTA DE PESQUISA-CUIDADO E FUNDAMENTAL ONLINE, 2014, 6 (03): : 1302 - 1312
  • [26] Hormone replacement New menopause therapy could cut cancer risk
    O'Driscoll, Cath
    CHEMISTRY & INDUSTRY, 2011, (14) : 9 - 9
  • [27] The Effect of Menopause and Menopausal Hormone Therapy on the Risk of Peripheral Artery Disease
    Anagnostis, Panagiotis
    Mikhailidis, Dimitri P.
    Blinc, Ales
    Jensterle, Mojca
    Jezovnik, Mateja K.
    Schernthaner, Gerit-Holger
    Antignani, Pier Luigi
    Studen, Katica Bajuk
    Sabovic, Miso
    Poredos, Pavel
    CURRENT VASCULAR PHARMACOLOGY, 2023, 21 (05) : 293 - 296
  • [28] Patients' understanding of risk: a qualitative study of decision-making about the menopause and hormone replacement therapy in general practice
    Walter, FM
    Britten, N
    FAMILY PRACTICE, 2002, 19 (06) : 579 - 586
  • [29] Breast Cancer Risk by Breast Density, Menopause, and Postmenopausal Hormone Therapy Use
    Kerlikowske, Karla
    Cook, Andrea J.
    Buist, Diana S. M.
    Cummings, Steve R.
    Vachon, Celine
    Vacek, Pamela
    Miglioretti, Diana L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (24) : 3830 - 3837
  • [30] Reassuring data regarding the use of hormone therapy at menopause and risk of breast cancer
    Pinkerton, JoAnn, V
    Wilson, Carolyn S.
    Kaunitz, Andrew M.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2022, 29 (09): : 1001 - 1004